CARDIFF ONCOLOGY, INC. Convertible Preferred Stock, Shares Issued upon Conversion
CARDIFF ONCOLOGY, INC. (CRDF) had Convertible Preferred Stock, Shares Issued upon Conversion of 863.85 thousand shares as of 2021-12-31, per its 10-K filed 2023-03-02.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2023-03-02
- 2021-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 863.85K shares.
- 2020-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 863.85K shares.
- 2019-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 333.33K shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2021-12-31 | 863.85K shares 10-K · filed 2023-03-02 |
| 2020-12-31 | 863.85K shares 10-K · filed 2022-02-24 |
| 2019-12-31 | 333.33K shares 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |